Pembrolizumab (pembro) plus enzalutamide (enza) in patients with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort C update
Dokumenttyp:
Meeting Abstract
Autor(en):
Mourey, L.; Conter, H. J.; Shore, N.; Berry, W. R.; Fong, P. C.; Piulats, J. M.; Appleman, L. J.; Todenhoefer, T.; Gravis, G.; Laguerre, B.; Gurney, H.; Retz, M.; Romano, E.; de Bono, J. S.; Kam, A. E.; Emmenegger, U.; Wu, H.; Qiu, P.; Schloss, C.; Yu, E. Y.